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Background: To lower the risk of complications, carotid angioplasty and stenting (CAS) has been proposed as an
alternative to open surgery for carotid artery stenosis after neck irradiation. However, there are little postoperative data
to support the benefits of this strategy. This study evaluated the outcome of CAS in patients who had undergone neck
irradiation.
Methods: This retrospective study was conducted at 15 vascular surgery or interventional radiology centers in
France between January 1998 and July 2006. A total of 135 patients (115 men) with a mean age of 67  8 years
(range, 43-88) underwent CAS for 149 irradiation-induced lesions. The interval between irradiation and discovery
of the lesions was 12  8 years. Mean diameter reduction was 81% (range, 50%-95%), and stenosis was symptomatic
in 34%. Contralateral carotid lesions were observed in 48% of patients, including thrombosis in 18 and stenosis
>50% in 53.
Results: Technical failure occurred during CAS in three cases. The overall technical success rate was 98%. A cerebral
protection device was used in 59%. No death, one transient ischemic attack, and two strokes occurred during the first
postoperative month. Mean follow-up was 30 months. Six patients were lost to follow-up. Survival rates were 93.9% at
1 year and 75.3% at 3 years. Complications after the first postoperative month included neurologic events in six, carotid
thrombosis in nine, and restenosis in 18. The rates of freedom from neurologic and anatomic events were, respectively,
96.2% and 93.2% at 1 year and 93.1% and 85.9% at 3 years.
Conclusion: The immediate outcome of CAS for irradiation-induced carotid artery stenosis was satisfactory. Medium-
term neurologic outcome was acceptable, but the incidence of anatomic events such as thrombosis and restenosis was
high. A randomized study is needed to confirm that the outcome of the endovascular and surgical therapy is comparable
in this indication. ( J Vasc Surg 2008;48:852-8.)Carotid angioplasty and stenting (CAS) has been under
investigation for two decades and was initially proposed for
patients at high risk for open surgery. Several studies using
various clinical and anatomic criteria to define high-risk
indications1,2 have shown that CAS and open surgery
achieve similar postoperative outcomes for treatment of
carotid artery stenosis.2,3
Irradiation-induced stenosis of the carotid artery is one
of the main high-risk entities for open surgical therapy.
Surgical access in these patients can be complicated, and
nerve injury or wound-healing problems are frequent.
Endovascular treatment has been proposed as an attrac-
tive alternative, but little data are available on the short-
and long-term outcome of CAS in this indication. More-
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852over, there are no large series. This study evaluated the
outcome of CAS for carotid artery stenosis after neck
irradiation by conducting a retrospective review of cases
collected from 15 French vascular surgery or interven-
tional radiology centers.
METHODS
Patients. This retrospective study included symp-
tomatic and asymptomatic patients with tight carotid
artery stenosis secondary to neck irradiation. Patients
were recruited between January 1998 and July 2006 at
15 French vascular surgery or interventional radiology
centers with experience in both surgical and endovascu-
lar treatment of carotid artery stenosis (Table I, online
only). During the study period, 135 patients with carotid
artery stenosis after neck irradiation were selected for
CAS. Selection for CAS was by the individual judgement
of the treating practitioner, according to clinical experi-
ence and learning curve, as well as patient anatomic
considerations with regard to CAS feasibility and contra-
indication for carotid endarterectomy.
Mean age was 67  8 years (range, 43-88 years), and
85% were men. General and cardiovascular risk factors
are listed in Table II. Neck irradiation was performed for
laryngeal cancer in 60%, oropharyngeal cancer in 26%,
and miscellaneous malignancies such as parotid, thyroid,
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tween radiotherapy and CAS was 12  8 years (range,
2-33 years). Prior neck surgery had been performed in 103
patients (76%), of which 15 had a permanent tracheostomy.
Procedural details. Bilateral CAS was done in 14
patients, resulting in treatment of a total of 149 carotid
arteries. Two high-grade stenoses on the same artery
were present in 18 patients. In all, 167 postirradiation
carotid lesions were proposed for CAS. The mean diam-
eter reduction, as assessed by duplex scanning, was
81%  7% (range, 50%-95%) and was confirmed by
reductions of 82%  6% (range, 60%-95%) on preproce-
dural or intraprocedural angiography. The degree of
stenosis was assessed on angiography according to North
American Symptomatic Carotid Endarterectomy Trial
(NASCET) criteria.
The side of involvement was the right in 82 (55%) and
left 67 (45%). Stenosis was located in the common carotid
artery in 46 patients, carotid bifurcation in 31, and internal
carotid artery in 90. The contralateral carotid axis exhibited
no significant lesions in 78 cases (52%), stenosis between
50% and 95% in 53 (36%), and occlusion in 18 (12%).
Unilateral evaluation of ipsilateral carotid lesions, as deter-
mined by neurologic consequences, showed 66% of steno-
ses (n  98) were asymptomatic and 34% were symptom-
atic, accounting for transient ischemic attacks (TIAs) in 43
patients and stroke in eight.
Most CAS procedures in this study were performed in a
radiology suite through femoral artery puncture under local
anesthesia. Long sheaths (6F or 7F) were used more often
than guiding catheters (Table III).
Cerebral protection devices were used in 59% of
procedures. At the beginning of the study, cerebral
protection was not available, but as protection devices
became available, their use increased progressively. At
the end of the study, cerebral protection was being used
routinely according to recommendations of the Endar-
terectomy Versus Angioplasty in Patients With Symp-
tomatic Severe Carotid Stenosis (EVA-3S) trial steering
Table II. Characteristics and risk factors in the patient
population
Characteristic Value
Age, mean  SD years (range) 67  8 (43-88)
Sex, No. (%)
Male 115 (85)
Female 20 (15)
Risk factors, No. (%)
Hypertension 98 (73)
Diabetes 12 (9)
Smoking 113 (86)
Hypercholesterolemia 69 (51)
Coronary disease 29 (21)
Peripheral arterial disease 31 (23)committee.4Whenever possible, self-expandable nonconic stents
were implanted. Stent models, diameters, and lengths
varied considerably, depending on the features of the
carotid lesion and operators’ preferences. The procedure
was considered successful if stent deployment was
achieved. In accordance with NASCET criteria, residual
stenosis was defined as narrowing20% at the end of the
procedure.
Preoperative medical treatment included platelet ag-
gregation inhibitors in all patients except seven who had
long-term treatment with warfarin. From 2003, 90% of
patients received two inhibitors at least 48 hours before the
procedure. During the procedure, all patients received in-
travenous heparin. Atropine was given to 24% of patients,
usually as a prophylactic measure (Table IV). After treat-
ment, a combination of clopidogrel (or ticlopidine before
2003) and aspirin was prescribed for at least 1 month in
Table III. Characteristics of the endovascular procedures
Percentage
Setting
Radiology suite 58
Operating room 42
Anesthesia
Local 86
General 14
Introduction technique
Femoral percutaneous 94
Femoral cut-down 6
Introducer type
Long sheath 69
Guiding catheter 31
Cerebral protection
Yes 59
No 41
Type of protection
Filter 75
Occlusive balloon 25
Type of stent
Carotid Wallstenta 62
Other 38
Residual stenosis
10% to 30% 6
30% *
aBoston Scientific, Natick, Mass.
*3 procedural failures required conversion to successful open surgery.
Table IV. Medical treatment used before and after
endovascular treatment
Treatment Pre-op, % Post-op, %
Aspirin alone 35 7
Clopidogrela alone 5 3
Clopidogrela  aspirin 55 85
Warfarin 5 5
Statin 24 . . .
aBefore 2003, ticlopidine was used instead of clopidogrel.85% of patients not undergoing long-term treatment with
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before the procedure and in 43% after the procedure.
Follow-up. Clinical data, technical features of the in-
tervention, and short- to medium-term results were retro-
spectively collected, and outcome was analyzed on an
intention-to-treat basis. None of the participating centers
performed an independent neurologic assessment. All pa-
tients underwent postprocedural duplex scanning 7 days
and at 3 or 6 months, according to individual center
practice. The interval between two consecutive duplex
scans was generally 6 or 12 months, according to individual
center practice. All surviving patients with successful CAS
had clinical examination and duplex scan 6 months be-
fore the end of the study.
Statistical analysis. Actuarial survival, freedom from
neurologic events, and freedom from anatomic events,
defined as restenosis or occlusion, were assessed for the
entire study population. Restenosis was defined as a
diameter reduction 50% measured by duplex scanning.
Univariate analysis was performed using 2 and Wil-
coxon tests. Cumulative survival estimates were assessed
using the life-table method. The SPSS computer pro-
gram (SPSS Inc, Chicago, Ill) was used to perform
statistical analysis.
RESULTS
Early outcome. Technical failure occurred in three
patients, for a technical success rate of 98%. In one
patient it was not possible to pass through the internal
carotid artery stenosis with the 0.014-inch wire. The
second patient had a type III aortic arch, and it was not
possible to catheterize the common carotid artery. These
two patients underwent emergency saphenous bypass
grafting and had no intraoperative or postoperative neu-
rologic events. In the third patient, dissection of com-
mon carotid artery occurred during catheterization. This
patient had an intraoperative stroke, underwent emer-
gency saphenous bypass grafting, and recovered with no
neurologic sequelae 3 days.
One patient had a postoperative stroke 90 minutes
after a technically successful procedure secondary to
stent thrombosis. He underwent emergency saphenous
bypass grafting and kept a minor motor deficit until he
died 18 months later from malignancy. Another patient
had TIA 1 day after a successful procedure. A duplex scan
after the TIA showed patent internal carotid artery with-
out residual stenosis.
No patient died during the 30-day postoperative pe-
riod. The 30-day combined stroke and death rate was 1.5%.
In the other patients with technically successful procedures,
intraoperative technical problems included difficulty in
catheterization of the common carotid artery in four, in-
ability to deploy the stent in correct position in one, and
spasm of the internal carotid artery in five. Overall, the rate
of intraoperative technical problems, including the three
technical failures, was 8.7% (13 of 149 procedures).
Additional postoperative morbidity was seizure in
one patient and groin hematoma in four. One patientwith groin hematoma underwent surgical revision with
repair of the femoral artery, and the other three were
observed. The overall postoperative morbidity rate, in-
cluding these five patients and the three who had neuro-
logic events, was 5.9%.
Long-term outcome. Follow-up was available for
126 patients (three technical failures and six lost to
follow-up). Mean follow-up was 30 months (range, 3-95
months). Thirty patients (22%) died during follow-up.
One patient died at 7 months after a stroke associated
with ipsilateral carotid in-stent restenosis. This patient
had iterative carotid dilatation for restenosis 3 months
after the initial procedure. Six patients died of cardiac
events. Cancer was the cause of death in 20 patients with
a mean follow-up of 27 months: three died of the initial
malignancy and 17 of secondary cancer. Mean follow-up
between CAS and death was 27 months in patients who
died of cancer and 25 months in those who died of other
causes. The cause of death was undetermined in three
patients. Cumulative survival was 93.9% at 1 year and
68% at 4 years (Table V, online only). The 96 surviving
patients with successful CAS were contacted 6 months
before the end of the study and had a clinical examina-
tion and duplex scan.
Six patients had ischemic neurologic events at mean
interval of 16 months (range, 2-56 months) consisting of
three TIAs and three strokes. TwoTIAs were due to carotid
thrombosis, and the other four neurologic events were
related restenosis. Restenosis was treated by open surgery
in one patient and repeat endovascular therapy in one
patient. In the remaining two patients, restenosis was not
treated due to the patients’ poor general condition. Neu-
rologic event-free survival rate was 96.2% at 1 year and
93.1% at 4 years (Table VI, online only).
Occlusion of the treated carotid axis occurred in nine
patients (6%) at a mean interval of 18 months (range, 0-72
months). Carotid occlusion was symptomatic in three (1
stroke and 2 TIAs) and asymptomatic in six. The patient
who sustained a postprocedural stroke underwent immedi-
ate carotid saphenous bypass grafting with subsequent mild
neurologic sequelae.
Two patients had early symptomatic thrombosis at
1.5 and 2 months; postoperative duplex scans in these
patients did not show residual stenosis. In the six asymp-
tomatic occlusions, diagnosis was made on follow-up
duplex scans. Two patients had 60% stenosis on duplex
imaging performed 6 and 12 months before thrombosis.
Two patients had 40% restenosis 6 and 18 months before
thrombosis. Two patients had no restenosis 3 and 9
months before thrombosis.
Restenosis50% was diagnosed in 18 patients (12%)
at mean interval of 30 months (range, 3-84 months).
Four patients were symptomatic (2 strokes and 2 TIAs),
and 14 were asymptomatic. One patient who died from
ipsilateral stroke has already been described. Restenosis was
treated by repeat angioplasty in three patients (1 symptom-
atic) and open surgery in two (1 symptomatic). No recur-
rent neurologic or anatomic events developed in these
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Thirteen patients with restenosis were kept under regular
surveillance, and asymptomatic thrombosis developed in
two during the following year. Restenosis or occlusion-
free survival rates were 92.1% at 1 year and 83.4% at 4
years (Table VII, online only).
Table VIII (online only) reports life-table data related
to any event-free survival, including neurologic and ana-
tomic. The Fig 1 summarizes life-table curves for patients,
neurologic event-free, anatomic event-free, and any event-
free survivals.
Predictive factors for neurologic and anatomic
events. Univariant or multivariant analysis was per-
formed to identify predictive factors for neurologic and
anatomic (occlusion and/or restenosis) events. The fol-
lowing factors were studied: age, gender, cardiovascular
history, vascular risk factors (diabetes, hypertension, hy-
percholesterolemia, smoking), interval between irradia-
tion and angioplasty, location of treated lesion, degree of
stenosis (60% vs60%), symptomatic vs asymptomatic
stenosis, contralateral carotid disease, occurrence of pro-
cedurally related complications, postoperative residual
stenosis, stent type (Wallstent [Boston Scientific, Natick,
Mass] vs other), use of cerebral protection device, use of
statins before and after CAS, and antiplatelet regimen.
Univariant analysis demonstrated that diabetes mellitus,
symptomatic stenosis, contralateral carotid disease, and
use of statins after CAS were predictive of anatomic
events during follow-up. The occurrence of procedurally
related complications was the only predictive factor for
postoperative neurologic events. Multivariant analysis
identified no predictive factors.
DISCUSSION
With a combined stroke and death rate of 1.5% at 1
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Fig 1. Life-table curves for patient, neurologic event-free, ana-
tomic event-free, and any event-free survival.month, the outcome of CAS after neck irradiation can beconsidered satisfactory. This result is comparable with
that of carotid angioplasty5 and with results described in
studies comparing surgical and endovascular treatment
in high-risk surgical patients.2,3 The early results ob-
tained in this multicenter study are slightly better than
those reported in the angioplasty arms of the Stent-
Protected Percutaneous Angioplasty Versus Carotid
Endarterectomy and EVA-3S6 trials that demonstrated
respective combined stroke and death rates of 7.7% and
9.6%. It should be emphasized, however, that all patients
in those two trials presented with symptomatic tight
atherosclerotic stenosis that is associated with a higher
risk of embolism during endovascular treatment. In our
study only 33% of patients were symptomatic, and ste-
noses were nonatherosclerotic lesions.
The technical success rate of CAS in our study was 98%
according to intention-to-treat analysis. This is in agree-
ment with the current data. Endovascular therapy is some-
times unfeasible due to vascular access problems that can
result from extensive aortoiliac occlusive disease and com-
plex anatomy of the aortic arch or origin of the supra-aortic
branches, or both. It should be emphasized that the present
series was not exhaustive, because some patients with ca-
rotid stenosis after neck irradiation were not selected for
angioplasty. The main reason was because patients with the
most favorable anatomy and the highest surgical risk were
preferentially selected for CAS. As a result of this limitation,
the good immediate success rate can only be interpreted as
meaning that CAS is a feasible treatment of postirradiation
carotid stenosis.
In addition to demonstrating good clinical results in
the first month, this study indicates that the long-term
clinical outcome of CAS for postirradiation stenosis is
satisfactory. The cumulative neurologic event-free sur-
vival rate at 3 years was 93%. Anatomic events, defined as
occlusion or restenosis, occurred in 27 carotid axes for an
overall anatomic failure rate of 18%. Seven of these
anatomic failures (26%) led to neurologic complications
(1 early occlusion, 6 secondary anatomic events). In view
of this finding, an increased long-term anatomic failure
rate should be considered the main drawback of this
technique. However, we found that the use of statins
after CAS decreased significantly the incidence of ana-
tomic events during follow-up. This confirms the impor-
tance of associated medical therapy after interventions
for radiation-induced carotid stenosis, as it has been
demonstrated for atherosclerotic carotid disease.
Neck irradiation for local malignant disease can cause
carotid arterial wall injury by three different mecha-
nisms.7 The first is ischemic necrosis induced by occlu-
sion of the vasa vasorum, with subsequent gradual re-
placement of elastic tissue and muscular fibers by fibrous
tissue. This replacement process leads to local sclerosis.
Another mechanism is adventitial fibroses causing ob-
struction. In this regard, Muzaffar, et al,8 observed that
neck irradiation induces a significant increase in the
thickness of the carotid wall during first year after irradi-
ation treatment. These two mechanisms may explain that
JOURNAL OF VASCULAR SURGERY
October 2008856 Favre et althe thrombosis rate after CAS for radiation-induced
stenoses is higher than in patients undergoing CAS for
atherosclerotic lesions. The third mechanism is acceler-
ation of the atherosclerotic process, even though radio-
therapy has been proposed to prevent postangioplasty
restenosis. The time interval between irradiation and
development of arterial hemodynamic changes varies
considerably. In our experience, it ranged from 2 to30
years. This wide range has been documented in other
reports.9,10
Cervical irradiation does not always lead to carotid
artery stenosis. According to Lam, et al,11 the incidence
of carotid stenosis after irradiation is correlated with the
type of cancer treated, with a higher incidence after
treatment of head and neck malignancy than hemato-
logic diseases. Nevertheless King, et al,12 observed a
significantly higher incidence of carotid disease in young
patients who underwent neck irradiation for Hodgkin
lymphoma. Cheng, et al,7 showed that significant postir-
radiation carotid artery stenosis is frequent in patients
with nasopharyngeal and laryngeal carcinoma. The same
authors also showed that significant carotid stenosis was
associated with age, smoking, and coronary disease.
Some evidence suggests that irradiation-induced steno-
sis may correspond to acceleration of the progression of
atherosclerotic lesions by local ischemia. However many
postirradiation stenoses affect the common carotid artery
that is not a “preferred” location of atherosclerotic lesions.
In the current series, stenosis involved the common carotid
artery in 28% of cases.
It is remarkable that most patients in this series died of
cancer and not of a cardiovascular event. Only three of the
20 cancer deaths resulted from the initial cancer, and a new
cancer developed in the rest. This is consistent with the
experience of Marcel, et al,13 who found in a series of 41
patients that the only predictor of death was the occurrence
of a new malignancy. One might question whether some
patients had cancer in evolution at the time of CAS. Al-
though we do not have data on cancer status at the time of
CAS, it is remarkable that the mean delay between irradia-
tion and CAS was 10 years in patients who died of cancer
and 12 years for the entire population. Furthermore, the
mean delay between CAS and death was not different
between the patients who died of cancer and the others (27
vs 25 months). When the survival in this population is
considered, it seems justified to offer interventional therapy
in cases of severe carotid artery stenosis to reduce the
potential risk of ipsilateral stroke.
Like previous surgical intervention and history of
tracheotomy, irradiation-induced tissue alterations have
been associated with difficulties during redo surgery,
increased risk of cranial nerve injury, wound-healing
problems, and local infection. In addition, irradiation-
induced alterations of the arterial wall hamper the perfor-
mance of endarterectomy. Seven studies9,10,14-18 have re-
ported 117 cases of surgical treatment of irradiation-
induced carotid artery stenosis. The largest series were those
of Leseche, et al,14 and Kashyap, et al,15 which included 30and 26 patients, respectively. Five smaller series were also
published between 1989 and 2001.9,10,16-18 In these previ-
ous reports, two patients presented with postoperative
stroke and one patient died of cerebral hemorrhage for a
combined stroke and death rate at 1 month of 2.6%,
which is comparable with the 1.5% observed in our
experience.
During follow-up in these previous reports, stroke de-
veloped in two patients, two patients had symptoms of
TIAs, and 10 showed a restenosis 60% or carotid occlu-
sion. Cranial nerve injury was observed in four patients.
Wound healing was incomplete in only one patient. With
regard to this latter issue, several authors9,15,17 have closed
the wound with musculocutaneous flaps. Despite all tech-
nical hurdles, the mean duration of the procedure was
generally not significantly increased.10
In most surgical reports, stenosis was repaired by
means of venous bypass grafting. However, Leseche,
et al,14 recommend the use of polytetrafluoroethylene
grafts for bypass surgery because of the high incidence of
anastomotic restenosis in venous grafts. Venous patches
are preferred to prosthetic patches, but Kashyap, et al,15
have not encountered complications with polyester
patches.
According to our literature search, the early and
medium-term results of conventional surgery appear
comparable with the results of angioplasty in our expe-
rience. From the seven series published between 1989
and 2005, we found that the mean anatomic failure rate
after open surgery was about 9%, which is lower than the
18% rate in our series. However, the 4% incidence of
neurologic events after CAS in our series compares favor-
ably with the 4.4% that was found from the literature in
open surgery. This is because many thromboses and reste-
noses in our series remained asymptomatic. It does not
appear from the above data that the benefit of CAS in terms
of reduction of postoperative morbidity is obviated by a
greater incidence of neurologic events during follow-up. It
therefore seems possible to recommend CAS as primary
treatment for stenosis after neck irradiation.
To compare our results with previous experience
using endovascular therapy, we compiled data from six
previous series19-24 describing patients with irradiation-
induced carotid stenoses treated by CAS (Table IX). The
six series comprised 90 carotid arteries in 80 patients,
including 59% who were symptomatic. In 20 cases, CAS
was performed on two lesions located on the same artery.
Cerebral protection devices were used in only 13 angio-
plasties (14%). By comparison, protection devices were
used in 59% of angioplasties in our more recent series.
Neurologic events occurred in 4% of patients in the
compiled series vs 2% in our experience. The previous
series did not mention additional neurologic events dur-
ing follow-up. We observed six events after the first
postoperative month due to occlusion in two cases or
restenosis in four at the site of angioplasty.
The overall neurologic complication rate after CAS
was satisfactory and comparable with that observed after
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restenosis (n  30) or occlusion (n  14) for all 239
published endoluminal treatments (including this re-
port) was high at 18%. After a mean follow-up of 14
months, Protack, et al,24 reported anatomic complica-
tions in 43% of cases treated by CAS, which is obviously
much higher than in other series, including our own
(13% and 18%, respectively). Despite these discrepancies,
it appears that restenosis and occlusion are more fre-
quent after CAS than conventional surgery.
CONCLUSION
The purpose of this multicenter retrospective analysis
was to evaluate the outcome of CAS for carotid irradiation-
induced stenosis at 15 French vascular surgery or interven-
tional radiology centers and compare the data with those
reported in the literature. Long-term clinical results were
comparable with previous reports, but anatomic results
were not as good as surgical treatment. A prospective
randomized study with a follow-up3 years will be neces-
sary to determine which treatment is better and which
clinical and anatomic factors should be taken into account
for therapeutic decision making.
AUTHOR CONTRIBUTIONS
Conception and design: JPF, BB, JPB
Analysis and interpretation: JPF, AN, JNA
Data collection: JPF, AD, BB, JPB
Writing the article: JPF, BB, JPB
Critical revision of the article: JPF, AN, AD, JNA
Final approval of the article: JPF, AN, AD, JNA, BB, JPB
Statistical analysis: AN
Obtained funding: Not applicable
Overall responsibility: JPF
REFERENCES
1. Ouriel K, Hertzer NR, Beven EG, O’hara PJ, Krajewski LP, Clair DG,
et al. Preprocedural risk stratification: identifying an appropriate popu-
lation for carotid stenting. J Vasc Surg 2001;33:728-32.
2. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, et
al. Protected carotid artery stenting versus endarterectomy in high-risk
patients. N Engl J Med 2004;351:1493-501.
3. Gray WA, Hopkins LN, Yadav S, Davis T, Wholey M, Atkinson R, et al.
Protected carotid stenting in high-surgical-risk patients: the ARCHeR
results. J Vasc Surg 2006;44:258-68.
4. Mas JL, Chatellier G, Beyssen B. Carotid angioplasty and stenting with
Table IX. Outcome of endovascular treatment of carotid
First author
Patients,
No.
Carotid
arteries,
No.
Symptomatic
carotid arteries,
No. (%)
Al Mubarak19 (2000) 14 15 10 (66)
Houdart20 (2001) 7 9 6 (66)
Alric21 (2002) 4 6 2 (33)
Ting22 (2004) 16 18 13 (72)
Harrod-Kim23 (2005) 16 19 . . .
Protack24 (2007) 23 23 11 (48)
Present series (2007) 135 149 51 (34)and without cerebral protection: clinical alert from the EndarterectomyVersus Angioplasty in Patients With Symptomatic Severe Carotid
Stenosis (EVA-3S) trial. Stroke 2004;35:18-20.
5. Safian RD, Bresnahan JF, Foster M, Foster M, Bacharach JM, Maini B,
et al. CREATE Pivotal Trial Investigators. Protected carotid stenting in
high-risk patients with severe carotid artery stenosis. J Am Coll Cardiol
2006;47:2384-9.
6. Luebke T, Aleksic M, Brunkwall J. Meta-analysis of randomized trials
comparing carotid endarterectomy and endovascular treatment. Eur J
Vasc Endovasc Surg 2007;34:470-9.
7. Cheng SW, Wu LL, Ting AC, Lau H, Lam LK, Wei WI. Irradiation-
induced extracranial carotid stenosis in patients with head and neck
malignancies. Am J Surg 1999;178:323-8.
8. Muzaffar K, Collins SL, Labropoulos N, BakerWH. A prospective study
of the effects of irradiation on the carotid artery. Laryngoscope 2000;
110:1811-4.
9. Friedell ML, Joseph BP, Cohen MJ, Horowitz JD. Surgery for
carotid artery stenosis following neck irradiation. Ann Vasc Surg
2001;15:13-8.
10. Hassen-Khodja R, Sala F, Declemy S, Lagrange JL, Bouillanne PJ, Batt
M. Surgical management of atherosclerotic carotid artery stenosis after
cervical radiation therapy. Ann Vasc Surg 2000;14:608-11.
11. Lam WW, Leung SF, So NM, Wong K, Liu K, Ku PK, et al. Incidence
of carotid stenosis in nasopharyngeal carcinoma patients after radiother-
apy. Cancer 2001;92:2357-63.
12. King LJ, Hasnain SN, Webb JA, Kingston JE, Shafford EA, Lister TA,
et al. Asymptomatic carotid arterial disease in young patients following
neck radiation therapy for Hodgkin lymphoma. Radiology 1999;213:
167-72.
13. Marcel M, Leys D, Mounier-Vehier F, Bertheloot D, Lartigau E, Pruvo
JP, et al. Clinical outcome in patients with high-grade internal carotid
artery stenosis after irradiation. Neurology 2005;65:959-61.
14. Leseche G, Castier Y, Chataigner O, Francis F, Besnard M, Thabut G,
et al. Carotid artery revascularization through a radiated field. J Vasc
Surg 2003;38:244-50.
15. Kashyap VS, Moore WS, Quinones-Baldrich WJ. Carotid artery repair
for radiation-associated atherosclerosis is safe and durable procedure. J
Vasc Surg 1999;29:90-6.
16. Atkinson JL, Sundt TM Jr, Dale AJ, Cascino TL, Nichols DA.
Radiation-associated atheromatous disease of the cervical carotid
artery: report of seven cases and review of the literature. Neurosur-
gery 1989;24:171-8.
17. Andros G, Schneider PA, Harris RW, Dulawa LB, Oblath RW, Salles-
Cunha SX.Management of arterial occlusive disease following radiation
therapy. Cardiovasc Surg 1996;4:135-42.
18. Rockman CB, Riles TS, Fisher FS, Adelman MA, Lamparello PJ. The
surgical management of carotid artery stenosis in patients with previous
neck irradiation. Am J Surg 1996;172:191-5.
19. Al-Mubarak N, Roubin GS, Iyer SS, Gomez CR, Liu MW, Vitek JJ.
Carotid stenting for severe radiation-induced extracranial carotid artery
occlusive disease. J Endovasc Ther 2000;7:36-40.
20. Houdart E, Mounayer C, Chapot R, Saint-Maurice JP, Merland JJ.
Carotid stenting for radiation-induced stenoses: a report of 7 cases.
y stenosis after neck irradiation reported in the literature
ree of
sis, %
Technical
success
rate, %
Post-op
stroke, No.
Mean
follow-up,
months
Restenosis,
occlusion during
follow-up, No. (%)
77 100 1 18 0
70 100 0 8 0
95 0 8 0
85 94 1 30 3
84 100 1 28 5
70 96 1 14 11 (48)
80 98 3 30 27 (18)arter
Deg
steno

Stroke 2001;32:118-21.
JOURNAL OF VASCULAR SURGERY
October 2008858 Favre et al21. Alric P, Branchereau P, Berthet JP, Mary H, Marty-Ané C. Carotid
artery stenting for stenosis following revascularization or cervical irra-
diation. J Endovasc Ther 2002;9:14-9.
22. Ting AC, Cheng SW, Yeung KM, Cheng P, Lui W, Ho P, et al. Carotid
stenting for radiation-induced extracranial carotid artery occlusive dis-
ease: efficacy and midterm outcomes. J Endovasc Ther 2004;11:53-9.
23. Harrod-Kim P, Kadkhodayan Y, Derdeyn CP, Cross DWT III, Moran
CJ. Outcomes of carotid angioplasty and stenting for radiation-24. Protack CD, Bakken AM, Saad WA, Illig KA, Waldman DL, Davies
MG. Radiation arteritis: a contraindication to carotid stenting? J Vasc
Surg 2007;45:110-7.
Submitted Feb 22, 2008; accepted May 28, 2008.
Additionalmaterial for this articlemay be found online at
associated stenosis. AJNR Am J Neuroradiol 2005;26:1781-8. www.jvascsurg.org.
COLLECTIONS OF PAPERS
On the Web version of the Journal, selected articles have been grouped together for the convenience of the
readers. The current collections include the following:
American Board of Vascular Surgery
Editorial Comments
History
Reporting Standards
Technical Notes
Basic Science Reviews
Guidelines
Lifeline Research Meeting Abstracts
Reviews
JOURNAL OF VASCULAR SURGERY
Volume 48, Number 4 Favre et al 858.e1Table I (online only). Centers and lead investigators that participated in this retrospective analysis of endovascular
treatment of irradiation-induced carotid artery stenosis
Investigator City Patients, No.
Carotid
arteries, No.
Beyssen B Paris 26 28
Becquemin JP Créteil 20 25
Magnan PE Marseille 14 15
Watelet J Rouen 13 13
Favre JP St Etienne 12 13
Midy D Bordeaux 10 12
Chevalier J Lille 8 9
Alric P Montpellier 7 9
Haulon S Lille 6 6
Reix T Amiens 5 5
Feugier P Lyon 4 4
Hassen-Khodja R Nice 4 4
Lermuziau P Tours 4 4
Enon J Angers 1 1
Chauffour X Toulouse 1 1
Total 135 149
Table V (online only). Life-table survival of patients who underwent endovascular treatment for carotid artery stenosis
after neck irradiation
Interval
start
time
No.
entering
this
interval
No.
withdrawn
during
interval
No.
exposed
to risk
No. of
terminal
events
Proportion
terminating
Proportion
surviving
Cumulative
proportion
surviving
at end
Probability
density
Hazard
rate
SE of
cumulative
surviving
.0 135.0 14.0 128.0 2.0 0.0156 0.9844 0.9844 .0026 0.0026 0.0110
6.0 119.0 18.0 110.0 5.0 0.0455 0.9545 0.9396 .0075 0.0078 0.0222
12.0 96.0 6.0 93.0 1.0 0.0108 0.9892 0.9295 .0017 0.0018 0.0241
18.0 89.0 11.0 83.5 8.0 0.0958 0.9042 0.8405 .0148 0.0168 0.0370
24.0 70.0 11.0 64.5 1.0 0.0155 0.9845 0.8274 .0022 0.0026 0.0387
30.0 58.0 4.0 56.0 5.0 0.0893 0.9107 0.7536 .0123 0.0156 0.0473
36.0 49.0 9.0 44.5 2.0 0.0449 0.9551 0.7197 .0056 0.0077 0.0509
42.0 38.0 4.0 36.0 2.0 0.0556 0.9444 0.6797 .0067 0.0095 0.0553
48.0 32.0 7.0 28.5 1.0 0.0351 0.9649 0.6559 .0040 0.0060 0.0583
54.0 24.0 5.0 21.5 0 0 1.0000 0.6559 0 0 0.0583
60.0 19.0 4.0 17.0 1.0 0.0588 0.9412 0.6173 .0064 0.0101 0.0664
SE, Standard error.
JOURNAL OF VASCULAR SURGERY
October 2008858.e2 Favre et alTable VI (online only). Life table of neurologic event-free survival rate of patients who underwent endovascular
treatment for carotid artery stenosis after neck irradiation
Interval
start
time
No.
entering
this
interval
No.
withdrawn
during
interval
No.
exposed
to risk
No. of
terminal
events
Proportion
terminating
Proportion
surviving
Cumulative
proportion
surviving
at end
Probability
density
Hazard
rate
SE of
cumulative
surviving
0 149.0 18.0 138.0 4.0 0.0290 0.9710 0.9710 .0048 0.0049 0.0143
6.0 125.0 23.0 113.5 1.0 0.0088 0.9912 0.9625 .0014 0.0015 0.0165
12.0 101.0 9.0 96.5 2.0 0.0207 0.9793 0.9425 .0033 0.0035 0.0214
18.0 90.0 16.0 82.0 1.0 0.0122 0.9878 0.9310 .0019 0.0020 0.0240
24.0 73.0 14.0 66.0 0 0 1.0000 0.9310 0 0 0.0240
30.0 59.0 7.0 55.5 0 0 1.0000 0.9310 0 0 0.0240
36.0 52.0 13.0 45.5 0 0 1.0000 0.9310 0 0 0.0240
42.0 39.0 5.0 36.5 0 0 1.0000 0.9310 0 0 0.0240
48.0 34.0 6.0 31.0 0 0 1.0000 0.9310 0 0 0.0240
54.0 28.0 8.0 24.0 1.0 0.0417 0.9583 0.8922 .0065 0.0071 0.0444
60.0 19.0 4.0 17.0 0 0 1.0000 0.8922 0 0 0.0444SE, Standard error.Table VII (online only). Life table of restenosis- or occlusion-free survival rate of patients who underwent
endovascular treatment for carotid artery stenosis after neck irradiation
Interval
start
time
No.
entering
this
interval
No.
withdrawn
during
interval
No.
exposed
to risk
No. of
terminal
events
Proportion
terminating
Proportion
surviving
Cumulative
proportion
surviving
at end
Probability
density
Hazard
rate
SE of
cumulative
surviving
0 149.0 19.0 139.5 5.0 0.0358 0.9642 0.9642 .0060 0.0061 0.0157
6.0 125.0 23.0 113.5 5.0 0.0441 0.9559 0.9217 .0071 0.0075 0.0239
12.0 97.0 9.0 92.5 3.0 0.0324 0.9676 0.8918 .0050 0.0055 0.0287
18.0 85.0 15.0 77.5 2.0 0.0258 0.9742 0.8688 .0038 0.0044 0.0322
24.0 68.0 13.0 61.5 1.0 0.163 0.9837 0.8547 .0024 0.0027 0.0347
30.0 54.0 7.0 50.5 0 0 1.0000 0.8547 0 0 0.0347
36.0 47.0 12.0 41.0 1.0 0.0244 0.9756 0.8338 .0035 0.0041 0.0396
42.0 34.0 4.0 32.0 0 0 1.0000 0.8338 0 0 0.0396
48.0 30.0 5.0 27.5 1.0 0.0364 0.9636 0.8035 .0051 0.0062 0.0484
54.0 24.0 6.0 21.0 4.0 0.1905 0.8095 0.6504 .0255 0.0351 0.0792
60.0 14.0 1.0 13.5 1.0 0.0741 0.9259 0.6023 .0080 0.0128 0.0868SE, Standard error.Table VIII (online only). Life-table data of any event-free survival, including neurologic and anatomic events, in
patients who underwent endovascular treatment for carotid artery stenosis after neck irradiation
Interval
start
time
No.
entering
this
interval
No.
withdrawn
during
interval
No.
exposed
to risk
No. of
terminal
events
Proportion
terminating
Proportion
surviving
Cumulative
proportion
surviving
at end
Probability
density
Hazard
rate
SE of
cumulative
surviving
0 135.0 17.0 126.5 5.0 0.0395 0.9605 0.9605 .0066 0.0067 0.0173
6.0 113.0 21.0 102.5 3.0 0.0293 0.9707 0.9324 .0047 0.0050 0.0232
12.0 89.0 8.0 85.0 3.0 0.0353 0.9647 0.8995 .0055 0.0060 0.0291
18.0 78.0 13.0 71.5 2.0 0.0280 0.9720 0.8743 .0042 0.0047 0.0333
24.0 63.0 12.0 57.0 1.0 0.0175 0.9825 0.8590 .0026 0.0029 0.0361
30.0 50.0 6.0 47.0 0 0 1.0000 0.8590 0 0 0.0361
36.0 44.0 12.0 38.0 1.0 0.0263 0.9737 0.8364 .0038 0.0044 0.0416
42.0 31.0 4.0 29.0 0 0 1.0000 0.8364 0 0 0.0416
48.0 27.0 5.0 24.5 1.0 0.0408 0.9592 0.8022 .0057 0.0069 0.0521
54.0 21.0 4.0 19.0 4.0 0.2105 0.7895 0.6333 .0281 0.0392 0.0856
60.0 13.0 1.0 12.5 1.0 0.0800 0.9200 0.5827 .0084 0.0139 0.0925
